Pregnancy and Fertility After UFE

Uterine fibroids affect a significant majority of women by the time they reach age fifty. While many remain asymptomatic, a large number of women experience debilitating symptoms such as heavy menstrual bleeding, severe pelvic pain, and uncomfortable bulk symptoms. When these symptoms interfere with daily life, seeking treatment becomes necessary. Historically, surgical options like hysterectomy or myomectomy were the standard recommendations. However, Uterine Fibroid Embolization has revolutionized fibroid care by offering a highly effective, minimally invasive alternative.

At North Star Fibroid Clinic, one of the most frequent and understandable concerns we address is how this procedure impacts future family planning. For women of reproductive age, preserving the uterus is only part of the equation; preserving the ability to conceive and carry a healthy pregnancy to term is equally critical. This comprehensive guide explores the deep clinical data surrounding pregnancy and fertility after UFE, examining everything from biological mechanisms and ovarian reserve to conception rates and specific obstetric outcomes

TL;DR 

UFE is a non surgical fibroid treatment that keeps your uterus intact. Research shows it does not damage your egg supply or hormone levels. Among women who were actively trying to get pregnant after UFE, a 52.1 percent conception rate was recorded across more than four thousand patients, with most conceptions happening within a year. This reflects the success rate of women in those studies, not a reduction from their pre-treatment fertility. Pregnancies after UFE are considered higher risk and need specialist care, but healthy births are well documented and absolutely possible. Unlike hysterectomy, which permanently ends the ability to carry a pregnancy, and myomectomy, which involves open surgery with a longer recovery, UFE offers a less invasive path that preserves both the uterus and future fertility.

The Biological Mechanism of UFE and Fertility

To understand how UFE affects fertility, it is helpful to understand the procedure itself. UFE is performed by an interventional radiologist who guides a tiny catheter into the uterine arteries. Small particles are then injected to block the blood flow specifically feeding the fibroids. Without a blood supply, the fibroids shrink and die, alleviating the associated symptoms.

The primary concern regarding fertility has always been the potential for “non target embolization.” The uterus and the ovaries share a complex network of blood vessels, including the utero ovarian anastomosis. The theoretical risk is that the embolic particles might travel through these connecting vessels and inadvertently reduce the blood supply to the ovaries, thereby affecting egg production and overall ovarian health. However, modern techniques and extensive clinical studies have shown that when performed by experienced specialists, the risk of significant, long term ovarian damage is remarkably low.

Preserving Ovarian Reserve

Ovarian reserve refers to the capacity of the ovaries to provide egg cells that are capable of fertilization. It is a fundamental component of a woman’s fertility. Clinical researchers measure ovarian reserve using specific hormonal markers, most notably Anti Müllerian Hormone and Follicle Stimulating Hormone.

Extensive clinical data provides a reassuring outlook for women undergoing UFE. A robust meta analysis investigating the impact of uterine artery embolization on ovarian reserve evaluated hundreds of patients across multiple studies. The researchers concluded that UFE does not significantly impair ovarian reserve over a twelve month follow up period. While the study noted a temporary decline in certain markers, such as the antral follicle count, at the three month mark, hormonal balances remained stable at six and twelve months.

Furthermore, a prospective cohort study tracking ovarian function and pregnancy outcomes followed patients for up to thirty six months. The researchers found no significant differences in the serum levels of reproductive hormones between women who underwent UFE and those who received conservative management. This indicates that the procedure effectively preserves the delicate hormonal environment required for reproduction over a prolonged period.

It is crucial to acknowledge that age is the most significant determining factor. Clinical evidence demonstrates that women under the age of forty are highly unlikely to experience premature menopause as a result of UFE. In contrast, women over the age of forty, who are already experiencing a natural decline in ovarian reserve, face an approximately twelve percent risk of experiencing ovarian dysfunction following the procedure.

Conception Rates Following UFE

The ultimate question for many patients is simply: Can I get pregnant after UFE? The clinical consensus is a definitive yes. Achieving a spontaneous pregnancy is entirely possible, and thousands of women have successfully conceived and delivered healthy babies after their procedures.

A recent, expansive meta analysis of twenty years of clinical evidence regarding UFE fertility outcomes analyzed data from over four thousand two hundred women treated for symptomatic fibroids. The study reported a pooled pregnancy rate of 52.1 percent among women who were actively attempting to conceive following their treatment. The data also revealed that the median time to conception was approximately twelve months, with a mean time of 14.7 months. This means that roughly half of the women who successfully conceived did so within about one year after their embolization.

Several key factors heavily influence these success rates:

• Patient Age: Age remains the strongest predictor of fertility success. The meta analysis found that pregnancy rates were highest in women under thirty five years of age, reaching 68.4 percent.
• Prior Fertility History: Women who had a history of successful pregnancies prior to undergoing UFE demonstrated a much higher conception rate of 57.3 percent, compared to 38.9 percent for those who were dealing with primary infertility before their treatment.
• Fibroid Burden: The size and location of the fibroids prior to treatment also play a role. Patients with massive fibroid volumes exceeding 200 cubic centimeters may face slightly lower conception rates of 41.2 percent, though pregnancy is still frequently achieved.

When discussing conception, it is common to compare UFE with myomectomy, the traditional surgical option for fertility preservation. Clinical trials suggest that myomectomy may yield slightly higher overall conception rates, generally reported between sixty and seventy percent. However, myomectomy is a major surgery that involves cutting into the uterine muscle, which carries risks of significant scarring, adhesions, and a much longer recovery period. For patients who wish to avoid invasive surgery, UFE remains an excellent, uterus sparing option.

Obstetric Outcomes and Pregnancy Considerations

Conceiving is the first milestone; carrying the pregnancy safely to term is the next. Women who become pregnant after UFE must be aware of specific obstetric considerations. Because the uterus has undergone a medical intervention, these pregnancies are generally monitored more closely.

Miscarriage Rates

The data regarding spontaneous abortion, or miscarriage, following UFE requires careful context. Some studies indicate an elevated risk of miscarriage compared to the general, healthy population. For example, research evaluating miscarriage rates after myomectomy and UFE found that the miscarriage rate was approximately 31 percent after UFE. Interestingly, this is statistically comparable to the 29 percent rate observed after robotic myomectomy. These findings suggest that the underlying fibroid disease itself, and the distortion it causes to the uterine environment, plays a significant role in pregnancy loss, regardless of the treatment method chosen.

Delivery Methods and Preterm Labor

When it comes to delivery, UFE presents a mixed but manageable clinical picture. The overall rate of cesarean sections for post UFE pregnancies is notably elevated, sitting at approximately 42 percent compared to a 31 percent population average. This higher rate is often driven by obstetric caution; many doctors prefer to schedule a cesarean delivery for patients with a history of significant uterine procedures to minimize risks during labor. Additionally, factors such as the baby presenting in a breech position can contribute to the higher cesarean rate.

Placental Health and Postpartum Monitoring

Ensuring placental health is a critical component of prenatal care for post UFE patients. An updated clinical review of pregnancy success after UFE highlighted an increased incidence of specific complications. Clinical data shows an 8.7 percent incidence of postpartum hemorrhage. There is also a 3.4 percent risk of placental abnormalities, specifically placenta accreta spectrum disorders, where the placenta attaches too deeply into the uterine wall. Because of these potential complications, it is highly recommended that women who conceive after UFE receive their prenatal care from specialists and plan their deliveries in facilities that are fully equipped to handle complex obstetric situations.

Making an Empowered Decision

Navigating the intersection of fibroid treatment and family planning is a deeply personal journey. At North Star Fibroid Clinic, we are committed to providing you with the comprehensive, evidence based information you need to make the best choice for your body and your future.

UFE is a highly effective, outpatient procedure that successfully shrinks fibroids, relieves debilitating symptoms, and preserves the uterus without the need for surgical incisions. The extensive clinical evidence confirms that natural pregnancy is highly attainable after UFE, with reassuring data supporting the preservation of ovarian reserve, particularly in women under forty.

While there are specific obstetric considerations to keep in mind, and while myomectomy may be recommended in certain specific cases, UFE stands as a powerful option for women seeking relief from fibroids while keeping their dreams of motherhood alive. By understanding the clinical realities and consulting with experienced specialists, you can move forward with confidence and clarity.